Global Ophthalmic Drugs Market Professional Survey Report 2017

 Table of Contents

Global Ophthalmic Drugs Market Professional Survey Report 2017
1 Industry Overview of Ophthalmic Drugs
    1.1 Definition and Specifications of Ophthalmic Drugs
        1.1.1 Definition of Ophthalmic Drugs
        1.1.2 Specifications of Ophthalmic Drugs
    1.2 Classification of Ophthalmic Drugs
        1.2.1 Dry Eye
        1.2.2 Glaucoma
        1.2.3 Infection/Inflammation
        1.2.4 Retinal Disorders
        1.2.5 Allergy
        1.2.6 Uveitis
        1.2.7 Others
    1.3 Applications of Ophthalmic Drugs
        1.3.1 Hospital Pharmacies
        1.3.2 Online Pharmacies
        1.3.3 Independent Pharmacies & Drug Stores
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Ophthalmic Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Ophthalmic Drugs
    2.3 Manufacturing Process Analysis of Ophthalmic Drugs
    2.4 Industry Chain Structure of Ophthalmic Drugs

3 Technical Data and Manufacturing Plants Analysis of Ophthalmic Drugs
    3.1 Capacity and Commercial Production Date of Global Ophthalmic Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Ophthalmic Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Ophthalmic Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Ophthalmic Drugs Major Manufacturers in 2016

4 Global Ophthalmic Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Ophthalmic Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Ophthalmic Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Ophthalmic Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Ophthalmic Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Ophthalmic Drugs Sales Price
        4.4.2 2016 Ophthalmic Drugs Sales Price Analysis (Company Segment)

5 Ophthalmic Drugs Regional Market Analysis
    5.1 North America Ophthalmic Drugs Market Analysis
        5.1.1 North America Ophthalmic Drugs Market Overview
        5.1.2 North America 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.1.4 North America 2016 Ophthalmic Drugs Market Share Analysis
    5.2 China Ophthalmic Drugs Market Analysis
        5.2.1 China Ophthalmic Drugs Market Overview
        5.2.2 China 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.2.4 China 2016 Ophthalmic Drugs Market Share Analysis
    5.3 Europe Ophthalmic Drugs Market Analysis
        5.3.1 Europe Ophthalmic Drugs Market Overview
        5.3.2 Europe 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.3.4 Europe 2016 Ophthalmic Drugs Market Share Analysis
    5.4 Southeast Asia Ophthalmic Drugs Market Analysis
        5.4.1 Southeast Asia Ophthalmic Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Ophthalmic Drugs Market Share Analysis
    5.5 Japan Ophthalmic Drugs Market Analysis
        5.5.1 Japan Ophthalmic Drugs Market Overview
        5.5.2 Japan 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.5.4 Japan 2016 Ophthalmic Drugs Market Share Analysis
    5.6 India Ophthalmic Drugs Market Analysis
        5.6.1 India Ophthalmic Drugs Market Overview
        5.6.2 India 2012-2017E Ophthalmic Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Ophthalmic Drugs Sales Price Analysis
        5.6.4 India 2016 Ophthalmic Drugs Market Share Analysis

6 Global 2012-2017E Ophthalmic Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Ophthalmic Drugs Sales by Type
    6.2 Different Types of Ophthalmic Drugs Product Interview Price Analysis
    6.3 Different Types of Ophthalmic Drugs Product Driving Factors Analysis
        6.3.1 Dry Eye of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.2 Glaucoma of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.3 Infection/Inflammation of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.4 Retinal Disorders of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.5 Allergy of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.6 Uveitis of Ophthalmic Drugs Growth Driving Factor Analysis
        6.3.7 Others of Ophthalmic Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Ophthalmic Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Ophthalmic Drugs Consumption by Application
    7.2 Different Application of Ophthalmic Drugs Product Interview Price Analysis
    7.3 Different Application of Ophthalmic Drugs Product Driving Factors Analysis
        7.3.1 Hospital Pharmacies of Ophthalmic Drugs Growth Driving Factor Analysis
        7.3.2 Online Pharmacies of Ophthalmic Drugs Growth Driving Factor Analysis
        7.3.3 Independent Pharmacies & Drug Stores of Ophthalmic Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Ophthalmic Drugs
    8.1 Aerie Pharmaceuticals
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Aerie Pharmaceuticals 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Aerie Pharmaceuticals 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.2 ALLERGAN
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 ALLERGAN 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 ALLERGAN 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.3 Valeant Pharmaceuticals International
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Valeant Pharmaceuticals International 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Valeant Pharmaceuticals International 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.4 Bayer AG
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Bayer AG 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Bayer AG 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.5 Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Genentech, Inc. (F. Hoffmann-La Roche Ltd.) 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Genentech, Inc. (F. Hoffmann-La Roche Ltd.) 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.6 Novartis AG
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Novartis AG 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Novartis AG 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.7 Pfizer
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Pfizer 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Pfizer 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.8 Regeneron Pharmaceuticals
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Regeneron Pharmaceuticals 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Regeneron Pharmaceuticals 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.9 Santen Pharmaceutical
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Santen Pharmaceutical 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Santen Pharmaceutical 2016 Ophthalmic Drugs Business Region Distribution Analysis
    8.10 Shire
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Shire 2016 Ophthalmic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Shire 2016 Ophthalmic Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Ophthalmic Drugs Market
    9.1 Global Ophthalmic Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Ophthalmic Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Ophthalmic Drugs Sales Price Forecast
    9.2 Ophthalmic Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Ophthalmic Drugs Consumption Forecast
        9.2.2 China 2017-2022 Ophthalmic Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Ophthalmic Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Ophthalmic Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Ophthalmic Drugs Consumption Forecast
        9.2.6 India 2017-2022 Ophthalmic Drugs Consumption Forecast
    9.3 Ophthalmic Drugs Market Trend (Product Type)
    9.4 Ophthalmic Drugs Market Trend (Application)

10 Ophthalmic Drugs Marketing Type Analysis
    10.1 Ophthalmic Drugs Regional Marketing Type Analysis
    10.2 Ophthalmic Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Ophthalmic Drugs by Region
    10.4 Ophthalmic Drugs Supply Chain Analysis

11 Consumers Analysis of Ophthalmic Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    …

12 Conclusion of the Global Ophthalmic Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures
    Figure Picture of Ophthalmic Drugs
    Table Product Specifications of Ophthalmic Drugs
    Table Classification of Ophthalmic Drugs
    Figure Global Production Market Share of Ophthalmic Drugs by Type in 2016
    Figure Dry Eye Picture
    Table Major Manufacturers of Dry Eye
    Figure Glaucoma Picture
    Table Major Manufacturers of Glaucoma
    Figure Infection/Inflammation Picture
    Table Major Manufacturers of Infection/Inflammation
    Figure Retinal Disorders Picture
    Table Major Manufacturers of Retinal Disorders
    Figure Allergy Picture
    Table Major Manufacturers of Allergy
    Figure Uveitis Picture
    Table Major Manufacturers of Uveitis
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Ophthalmic Drugs
    Figure Global Consumption Volume Market Share of Ophthalmic Drugs by Application in 2016
    Figure Hospital Pharmacies Examples
    Table Major Consumers of Hospital Pharmacies
    Figure Online Pharmacies Examples
    Table Major Consumers of Online Pharmacies
    Figure Independent Pharmacies & Drug Stores Examples
    Table Major Consumers of Independent Pharmacies & Drug Stores
    Figure Market Share of Ophthalmic Drugs by Regions
    Figure North America Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Figure China Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Figure Europe Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Figure Japan Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Figure India Ophthalmic Drugs Market Size (Million USD) (2012-2022)
    Table Ophthalmic Drugs Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Ophthalmic Drugs in 2016
    Figure Manufacturing Process Analysis of Ophthalmic Drugs
    Figure Industry Chain Structure of Ophthalmic Drugs
    Table Capacity and Commercial Production Date of Global Ophthalmic Drugs Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Ophthalmic Drugs Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Ophthalmic Drugs Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Ophthalmic Drugs Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Ophthalmic Drugs 2012-2017
    Figure Global 2012-2017E Ophthalmic Drugs Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Ophthalmic Drugs Market Size (Value) and Growth Rate
    Table 2012-2017E Global Ophthalmic Drugs Capacity and Growth Rate
    Table 2016 Global Ophthalmic Drugs Capacity (K Units) List (Company Segment)
    Table 2012-2017E Global Ophthalmic Drugs Sales (K Units) and Growth Rate
    Table 2016 Global Ophthalmic Drugs Sales (K Units) List (Company Segment)
    Table 2012-2017E Global Ophthalmic Drugs Sales Price (USD/Unit)
    Table 2016 Global Ophthalmic Drugs Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E 
    Figure North America 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit)
    Figure North America 2016 Ophthalmic Drugs Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E 
    Figure China 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit) 
    Figure China 2016 Ophthalmic Drugs Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E
    Figure Europe 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit)
    Figure Europe 2016 Ophthalmic Drugs Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E
    Figure Southeast Asia 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit)
    Figure Southeast Asia 2016 Ophthalmic Drugs Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E
    Figure Japan 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit)
    Figure Japan 2016 Ophthalmic Drugs Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Ophthalmic Drugs 2012-2017E
    Figure India 2012-2017E Ophthalmic Drugs Sales Price (USD/Unit)
    Figure India 2016 Ophthalmic Drugs Sales Market Share
    Table Global 2012-2017E Ophthalmic Drugs Sales (K Units) by Type
    Table Different Types Ophthalmic Drugs Product Interview Price
    Table Global 2012-2017E Ophthalmic Drugs Sales (K Units) by Application
    Table Different Application Ophthalmic Drugs Product Interview Price
    Table Aerie Pharmaceuticals Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Aerie Pharmaceuticals Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Aerie Pharmaceuticals Ophthalmic Drugs Business Region Distribution
    Table ALLERGAN Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 ALLERGAN Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 ALLERGAN Ophthalmic Drugs Business Region Distribution
    Table Valeant Pharmaceuticals International Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Valeant Pharmaceuticals International Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Valeant Pharmaceuticals International Ophthalmic Drugs Business Region Distribution
    Table Bayer AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Bayer AG Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Bayer AG Ophthalmic Drugs Business Region Distribution
    Table Genentech, Inc. (F. Hoffmann-La Roche Ltd.) Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Genentech, Inc. (F. Hoffmann-La Roche Ltd.) Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Genentech, Inc. (F. Hoffmann-La Roche Ltd.) Ophthalmic Drugs Business Region Distribution
    Table Novartis AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Novartis AG Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Novartis AG Ophthalmic Drugs Business Region Distribution
    Table Pfizer Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Pfizer Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Pfizer Ophthalmic Drugs Business Region Distribution
    Table Regeneron Pharmaceuticals Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Regeneron Pharmaceuticals Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Regeneron Pharmaceuticals Ophthalmic Drugs Business Region Distribution
    Table Santen Pharmaceutical Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Santen Pharmaceutical Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Santen Pharmaceutical Ophthalmic Drugs Business Region Distribution
    Table Shire Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Shire Ophthalmic Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2016 Shire Ophthalmic Drugs Business Region Distribution
    Figure Global 2017-2022 Ophthalmic Drugs Market Size (K Units) and Growth Rate Forecast
    Figure Global 2017-2022 Ophthalmic Drugs Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Ophthalmic Drugs Sales Price (USD/Unit) Forecast
    Figure North America 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2017-2022 Ophthalmic Drugs Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Ophthalmic Drugs by Type 2017-2022
    Table Global Consumption Volume (K Units) of Ophthalmic Drugs by Application 2017-2022
    Table Traders or Distributors with Contact Information of Ophthalmic Drugs by Region

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy